Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
European Journal of Cancer & Clinical Oncology|July 1, 1984
A sensitive assay for the pharmacokinetic investigation of a rapidly hydrolyzing alkylating agent Lycurim (ritrosulfan; R-74; NSC-122 402)L Hegedüs, S Kerpel-Fronius, I P Horváth, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Influence of toremifene on the endocrine regulation in breast cancer patientsI Számel, I Hindy, B Vincze, et al.Strahlentherapie|March 1, 1980
Clinical trials with MTDQ /6,6'-methylene-bis (2,2,4-trimethyl-1,2-dihydroquinoline)/ an antioxidant with radiation sensitizing effectV Erdélyi, V Bär, Z Pollák, et al.Neoplasma|January 1, 1990
Vinblastine, cisplatin and bleomycin treatment of advanced nonseminomatous testicular tumorsI Bodrogi, M Baki, J Horti, et al.European Journal of Cancer & Clinical Oncology|November 1, 1982
Metabolism and pharmacokinetics of dibromodulcitol (DBD, NSC-104800) in man--II. pharmacokinetics of DBDI P Horváth, J Csetényi, I Hindy, et al.Acta Medica Hungarica|January 1, 1994
Cisplatin containing combination chemotherapy of advanced germ cell line testicular tumoursI Bodrogi, M Baki, J Horti, et al.Oncology|January 1, 1988
Activity of epirubicin and dibromodulcitol in advanced breast cancer. Results of the South-East European Oncology Group StudyS Eckhardt, E Juhos, I Hindy, et al.Oncology|January 1, 1987
Activity of epirubicin in combination chemotherapy of advanced ovarian cancer. Results of the South-East European Oncology Group (SEEOG) StudyS Eckhardt, J Szántó, O Cerar, et al.Oncology|January 1, 1987
Phase I-II trial of aclacinomycin A given in a four-consecutive-day schedule to patients with solid tumours. A South-East European Oncology Group (SEEOG) StudyS Kerpel-Fronius, F Gyergyay, I Hindy, et al.Journal of Steroid Biochemistry|June 22, 1990
Hormonal effects of toremifene in breast cancer patientsI Számel, B Vincze, I Hindy, et al.Pageof 3